First Time Loading...

EKF Diagnostics Holdings PLC
LSE:EKF

Watchlist Manager
EKF Diagnostics Holdings PLC Logo
EKF Diagnostics Holdings PLC
LSE:EKF
Watchlist
Price: 30.14 GBX 1.14%
Updated: May 3, 2024

EKF Diagnostics Holdings PLC
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

EKF Diagnostics Holdings PLC
Revenue Peer Comparison

Comparables:
SN
LIVN
LMDX
AGL
CREO

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
EKF Diagnostics Holdings PLC
LSE:EKF
Revenue
£52.6m
CAGR 3-Years
-7%
CAGR 5-Years
4%
CAGR 10-Years
5%
Smith & Nephew PLC
LSE:SN
Revenue
$5.5B
CAGR 3-Years
7%
CAGR 5-Years
3%
CAGR 10-Years
N/A
LivaNova PLC
NASDAQ:LIVN
Revenue
$1.2B
CAGR 3-Years
7%
CAGR 5-Years
1%
CAGR 10-Years
N/A
LumiraDx Ltd
NASDAQ:LMDX
Revenue
$254.5m
CAGR 3-Years
123%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Angle PLC
LSE:AGL
Revenue
£1.8m
CAGR 3-Years
31%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Creo Medical Group PLC
LSE:CREO
Revenue
£27.2m
CAGR 3-Years
1 163%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is EKF Diagnostics Holdings PLC's Revenue?
Revenue
52.6m GBP

Based on the financial report for Dec 31, 2023, EKF Diagnostics Holdings PLC's Revenue amounts to 52.6m GBP.

What is EKF Diagnostics Holdings PLC's Revenue growth rate?
Revenue CAGR 10Y
5%

Over the last year, the Revenue growth was -21%. The average annual Revenue growth rates for EKF Diagnostics Holdings PLC have been -7% over the past three years , 4% over the past five years , and 5% over the past ten years .